• 1

    Boulton, AJM, FA Gries, and JA Jervell. :Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. .Diabetic Medicine 15::508. ,1998. .

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Emery, AE. :Population frequencies of inherited neuro-muscular diseases–a world survey. .Neuromuscul Disord 1::19. ,1991. .

  • 3

    Birouk, N, R Gouider, E Le Guern, et al. :Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication: clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. .Brain 120::813. ,1997. .

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Freitas, MR, OJ Nascimento, L Chimelli, et al. :Charcot-Marie-Tooth disease. Study of sural nerve biopsy in 41 patients. .Arq Neuropsiquiatr 53::560. ,1995. .

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Sheth, S, K Francies, CE Siskind, et al. :Diabetes mellitus exacerbates motor and sensory impairment in CMT1A. .J Peripher Nerv Syst 13::299. ,2008. .

    • Crossref
    • PubMed
    • Web of Science
    • Search Google Scholar
    • Export Citation
  • 6

    Wild, S, G Roglic, A Green, et al. :Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. .Diabetes Care 27::1047. ,2004. .

  • 7

    Celik, M, H Forta, Y Parman, et al. :Charcot-Marie-Tooth disease associated with Type 2 diabetes mellitus. .Diabet Med 18::685. ,2001. .

  • 8

    Koç, F, Y Sarica, D Yerdelen, et al. :A large family with Charcot-Marie-Tooth Type 1a and Type 2 diabetes mellitus. .Int J Neurosci 116::103. ,2006. .

  • 9

    Ota, T and K Osawa. :Marked improvement of glycaemic control with pioglitazone in a Type 2 diabetic patient associated with Charcot-Marie-Tooth disease. .Diabet Med 20::420. ,2003. .

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10

    Shy, ME, J Blake, K Krajewski, et al. :Reliability and validity of the CMT neuropathy score as a measure of disability. .Neurology 64::1209. ,2005. .

  • 11

    Takakura, Y, H Furuya, K Yamashita, et al. :A case of Charcot-Marie-Tooth disease (CMT) type 1 complicated by diabetes mellitus (DM) showing bilateral phrenic nerve palsy. .Rinsho Shinkeigaku 42::320. ,2002. .

    • PubMed
    • Search Google Scholar
    • Export Citation

Charcot-Marie-Tooth Disease Complicating Type 2 Diabetes

Htet Htet Ne Win MB, BCh, BAO, LRCP & SI1, Colin Davenport MB, BCh, BAO, MRCPI1, Siobhan Delaney BSc1, Margaret Kelly BSc1, and Diarmuid Smith MD, FRCPI1
View More View Less
  • 1 Department of Academic Endocrinology, Beaumont Hospital, Dublin, Ireland.
Restricted access

Although both conditions are relatively common, there are very few descriptions of type 2 diabetes mellitus coexisting with Charcot-Marie-Tooth disease (CMT). This case report and literature review describes a 53-year-old Irish man who presented with type 2 diabetes and significant neuropathy, and who was subsequently diagnosed with CMT type 1A. This case report will also discuss how to differentiate diabetic neuropathy from a progressive hereditary neuropathy and how coexistence aggravates the progression of neuropathy thus necessitating early diagnosis. (J Am Podiatr Med Assoc 101(4): 349–352, 2011)

Corresponding author: Htet Htet Ne Win, Department of Academic Endocrinology, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland. (E-mail: hnewin@gmail.com)